Volume 34, Issue 11
RESEARCH ARTICLE

Validation study of the Alzheimer's Disease Assessment Scale‐Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities

Hongyu Yang

The Affiliated Wuxi Mental Health Center of Nanjing Medical University, Wuxi, China

Search for more papers by this author
Zaohuo Cheng

Corresponding Author

E-mail address: zaohuocheng@sina.com

The Affiliated Wuxi Mental Health Center of Nanjing Medical University, Wuxi, China

Correspondence

Z. Cheng, The Affiliated Wuxi Mental Health Center of Nanjing Medical University, Wuxi, China.

Email: zaohuocheng@sina.com

Search for more papers by this author
Zemei Li

School of humanities and management, Graduate School of Wannan Medical College, Wuhu, China

Search for more papers by this author
Yan Jiang

The Affiliated Wuxi Mental Health Center of Nanjing Medical University, Wuxi, China

Search for more papers by this author
Jinfa Zhao

School of humanities and management, Graduate School of Wannan Medical College, Wuhu, China

Search for more papers by this author
Yue Wu

The Affiliated Wuxi Mental Health Center of Nanjing Medical University, Wuxi, China

Search for more papers by this author
Shouquan Gu

The Affiliated Wuxi Mental Health Center of Nanjing Medical University, Wuxi, China

Search for more papers by this author
Hong Xu

Beijing Anding Hospital, Capital Medical University, Beijing, China

Search for more papers by this author
First published: 26 July 2019

Abstract

Objective

Our study aimed to verify the validity of the Chinese version of Alzheimer's Disease Assessment Scale‐Cognitive Subscale (ADAS‐Cog) for the community‐dwelling older people in China.

Methods

A total of 1276 individuals composed by 628 normal controls (NCs), 572 people living with mild cognitive impairment (MCI), and 76 people living with Alzheimer's disease (AD) were recruited for the current study. All of the participants underwent ADAS‐Cog, clinical interview and examination, Quick Cognitive Screening Scale for the Elderly, and Activities of Daily Living Scale. The sensitivity and specificity of ADAS‐Cog were calculated, and a receiver operating characteristic curve (ROC curve) was drawn to decide the optimal cutoff points of ADAS‐Cog for screening MCI and AD.

Results

Statistically significant differences were observed among the three groups (P <. 001, NC < MCI <AD), in terms of the total and subtask scores of ADAS‐Cog. The optimal cutoff value for MCI was 10 points with an area under the curve (AUC) of 0.824, sensitivity of 61.4%, and specificity of 93.2%. Comparatively, the best cutoff value for AD was 15 points with an AUC of 0.905, sensitivity of 73.7%, and specificity of 92.4%. The overall accuracy was 70.5%, and the accuracy of diagnosing cognitively healthy older people, MCI patients, and AD patients was 81.7%, 58.0%, and 71.1%, respectively.

Conclusion

The present study illustrates that the Chinese version of the ADAS‐Cog total score is able to detect cognitive impairment of AD patients in Chinese communities but has a lower efficacy for MCI.

DATA AVAILABILITY STATEMENT

The data used in the present study are freely available upon reasonable request. When data have been shared, authors are required to include in their data availability statement a link to the repository they have used, and to cite the data they have shared. If sharing data compromises ethical standards or legal requirements, then authors are not expected to share it.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.